EndoQuest Robotics, a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies, has submitted an Investigational Device Exemption (IDE) application for its pivotal colorectal clinical study.
EndoQuest says its mission is to “transform surgical outcomes for minimally invasive surgery” (MIS) with its groundbreaking flexible robotic system.
This IDE will enable EndoQuest to begin their Prospective Assessment of a Robotic-Assisted Device in Gastrointestinal Medicine (PARADIGM) study, which is a prospective, multi-center, open-label study. [Read more…] about EndoQuest Robotics applies for FDA approval for its new robotic surgery device